Express & Expedited Shipping Service
USD $15.90
Products matching the full generic name: Glyceryl Trinitrate / Nitroglycerin
IndiaMonit GTN Controlled Release is a medication used primarily for the management of angina pectoris (chest pain) associated with coronary artery disease. It contains Glyceryl Trinitrate, also known as Nitroglycerin, which works by relaxing the blood vessels, allowing blood to flow more easily to the heart.
Glyceryl Trinitrate is a nitrate that dilates blood vessels, which decreases the workload on the heart and increases the supply of blood and oxygen to the heart muscle. This action helps to relieve the symptoms of angina.
Follow your healthcare provider's instructions regarding the dosage and administration of Monit GTN Controlled Release. It is typically taken orally, and patients should not exceed the recommended dosage.
Some common side effects may include headaches, dizziness, and flushing. Serious side effects are rare but can occur. It is important to consult with a healthcare professional if you experience any unusual symptoms or reactions.
Consult with your healthcare provider before using Monit GTN if you are pregnant or breastfeeding.
Monit GTN may cause dizziness; it is advisable to assess your response to the medication before driving or operating heavy machinery.
Store in a cool, dry place away from direct sunlight and out of reach of children.
Monit GTN Controlled Release is an effective treatment option for individuals suffering from angina pectoris. Always consult your healthcare provider for personalized advice and treatment plans.
Health Guides
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 30, 2026
Tacrolimus monitoring measures the tacrolimus level in whole blood to help balance organ rejection prevention against drug-related toxic effects. The result is useful only when interpreted against the dose and formulation. A routine trough sample is collected immediately before the next dose, usuall
Oct 28, 2026
Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration
Oct 23, 2026
Vitamin B12 deficiency can cause anemia, fatigue and nerve damage, but symptoms alone can't confirm the diagnosis. Blood tests help establish whether B12 is low and whether poor intake or impaired absorption explains the result. Early treatment matters because neurological damage can become permanen
Oct 22, 2026
Parkinson's disease medications improve movement by replacing dopamine, stimulating its receptors, or slowing its breakdown. Carbidopa-levodopa remains the most effective treatment for movement symptoms, while other medicines address milder symptoms, wearing-off, or involuntary movements. Treatment
Oct 20, 2026
Methimazole for hyperthyroidism reduces excess thyroid hormone production without destroying the thyroid gland. Treatment usually starts with a higher dose, followed by blood-test-guided reductions as hormone levels return to normal. This guide to methimazole hyperthyroidism treatment covers testing
Oct 19, 2026
Atrial fibrillation medications address three goals: rate control for a fast heart rate, rhythm control for an abnormal rhythm, and stroke prevention with anticoagulants that reduce blood clots. For atrial fibrillation, the regimen depends on stroke risk, heart and kidney function, and other prescri
Oct 17, 2026
Heart failure medications reduce strain on the heart, control fluid buildup, and lower the risk of hospitalization. Several drug classes also improve survival in people with reduced ejection fraction, although medicines don't cure heart failure. Treatment usually combines medicines because each addr
Oct 16, 2026
SGLT2 inhibitors lower blood glucose by helping the kidneys remove glucose through urine. Selected medicines also reduce heart-failure events and slow chronic kidney disease progression, so prescribing decisions extend beyond blood sugar alone. The short answer: SGLT2 inhibitors can benefit people
Oct 15, 2026
Potassium salt substitutes can lower sodium intake and blood pressure, but some hypertension medicines make the extra potassium unsafe. The main concern is hyperkalemia, an elevated blood potassium level that can disturb the heart's rhythm. Safety depends on kidney function, the complete medication
